Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg

NCT00648778 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Loxapine Succinate Capsules 25 mg
DRUG: Loxitane® Capsules 25 mg

Sponsor

Mylan Pharmaceuticals Inc